Role of mitral valve repair in infective endocarditis

Abstract

Insights

Mitral valve reconstruction (MVP) for mitral regurgitation (MR) caused by infective endocarditis (IE) demonstrated successful clinical outcomes. Careful patient selection and standard repair techniques are key to achieving excellent results in MVP for IE.

Area of Science:

  • Cardiovascular Surgery
  • Infectious Diseases
  • Valvular Heart Disease

Background:

  • Degenerative mitral regurgitation (MR) is typically treated with mitral valve reconstruction (MVP).
  • Mitral regurgitation due to infective endocarditis (IE) presents unique challenges for repair due to diverse pathophysiology.
  • This study analyzes the clinical experience of MVP for MR caused by IE.

Purpose of the Study:

  • To evaluate the clinical outcomes of mitral valve reconstruction (MVP) in patients with mitral regurgitation (MR) secondary to infective endocarditis (IE).
  • To assess the feasibility and efficacy of various repair techniques in complex IE-related MR cases.
  • To determine the factors influencing the decision between valve repair and replacement in this patient population.

Main Methods:

  • A retrospective review of 26 patients with MR due to IE who underwent surgery between 2004 and 2011.
  • Mitral valve reconstruction (MVP) was performed in 11 patients, utilizing techniques such as ring annuloplasty, triangular resection, and pericardial patch reconstruction.
  • Valve replacement was performed in 6 patients due to comorbidities or complex pathology.

Main Results:

  • No residual MR was observed postoperatively in the MVP group, with no early or late deaths.
  • No new MR developed during a mean follow-up of 35.7 months in the repair group.
  • Three non-cardiac deaths occurred in the valve replacement group during follow-up.

Conclusions:

  • Mitral valve reconstruction (MVP) is a successful treatment option for MR caused by IE.
  • Standard repair techniques are effective, but careful consideration of comorbidities is crucial for decision-making.
  • Excellent clinical outcomes can be achieved with judicious patient selection and appropriate surgical strategy.

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
356
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
502
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
855
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.7K
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
664
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K